Sartorius Stedim Biotech Shares Climb 1.5%, Targeting €183.70
The French bioproduction equipment specialist resumes its upward trajectory in mid-morning trading, with the SBF 120 showing a strong upward trend. The stock confirms the momentum established since mid-May and is approaching a closely watched technical threshold. The session is part of a European market buoyed by easing oil tensions following the preliminary agreement between Washington and Tehran.
The stock resumes its upward trajectory, approaching the €183.70 threshold
Sartorius Stedim Biotech shares are up 1.54% at €178.10 in mid-morning trading, while the SBF 120 has gained 0.73%. The stock continues the upward trend that began in mid-May, now showing a gain of over 14% over the month, which partially offsets the 10.5% decline accumulated over the year. In the shorter term, the week remains slightly negative (-0.7%), indicating a pause after the rapid rebound in May.
The price is moving above the 20-day moving average (€174.72) and the 50-day moving average (€170.65), confirming the medium-term recovery, but remains below the 200-day moving average at €185.38, with a nearly 4% gap that reflects the lag since last fall. The RSI at 54 indicates a neutral momentum, without extremes. The resistance threshold of €183.70, already identified as the upper limit during the end of May sessions, now frames the continuation of the movement.
An easing in oil tensions supports European stocks this Tuesday
Tuesday's European session benefits from the preliminary agreement signed on Sunday between the United States and Iran, which extends the 60-day ceasefire and includes the reopening of the Strait of Hormuz. Brent crude dropped about 4% the day before, around $83 a barrel, fueling a relief rally across indices: the CAC 40 is up 0.77%, the DAX 1.14%. According to a consensus of analysts surveyed, the stock is trading at about 35.3 times the earnings expected for the current fiscal year and 29.4 times those of 2027, a multiple that reflects expectations for a gradual improvement in margins after two years of post-Covid normalization.
The calendar for the coming weeks will be largely shaped by the FOMC meeting on June 16 and 17, the first under the chairmanship of Kevin Warsh, whose tone could influence European growth stocks. In the short term, the €183.70 zone remains the central technical reference for the continuation of the movement.
